CLINICAL AND PARACLINICAL CHARACTERISTICS OF PEDIATRIC TOXOCARIASIS AT THE VIETNAM NATIONAL CHILDREN’S HOSPITAL
Main Article Content
Abstract
Toxocariasis is a parasitic infection caused by the larval forms of Toxocara canis or Toxocara cati, transmitted to humans, especially children through the gastrointestinal tract following contact with contaminated environments or animals. Aims: To describe the clinical and paraclinical characteristics of pediatric toxocariasis at the Vietnam National Children’s Hospital. Materials and methods: A descriptive case series study was conducted on 74 children diagnosed with toxocariasis and treated at the Vietnam National Children’s Hospital from January 1, 2022, to June 30, 2025. Results: Of the total cases, 41.9% occurred in children under 6 years old and 48.6% in those aged 6–12 years, with a mean age of 7.3 ± 4.1 years. Boys accounted for 55.4% of the patients. Children from rural and mountainous areas represented 50% and 32.4% of cases, respectively. A history of household dogs or cats was present in 67.6%, with close contact reported in 48.6%.The most common clinical symptom was fever (82.4%). Gastrointestinal, neurological, and respiratory symptoms were observed in 45.9%, 29.7%, and 23% of patients, respectively. Cutaneous manifestations were relatively rare (10.8%). Peripheral eosinophilia was observed in 63.5% of patients, with a mean eosinophil count of 2.6 ± 1.2 G/L. Total IgE levels exceeded four times the upper normal limit in 54.1% of cases. Elevated AST and ALT levels were found in 24.3% and 18.9% of patients, respectively. Conclusions: Pediatric toxocariasis is frequently linked to exposure to domestic animals. Clinical manifestations are often nonspecific, making diagnosis challenging. However, peripheral eosinophilia, elevated total IgE, and characteristic hepatic lesions on imaging are valuable diagnostic indicators.
Article Details
Keywords
children, parasitic infection, Toxocara
References
2. Wiśniewska-Ligier M, Woźniakowska-Gęsicka T, Sobolewska-Dryjańska J, et al. Analysis of the course and treatment of toxocariasis in children-a long-term observation. Parasitology research. 2012;110(6):2363-2371.
3. A. Rostami, S. M. Riahi, C. V. Holland, et al. Seroprevalence estimates for toxocariasis in people worldwide: A systematic review and meta-analysis. PLoS neglected tropical diseases. 2019;13(12):e0007809.
4. Bùi Văn Tuấn, Nguyễn Văn Chương. Nghiên cứu một số đặc điểm dịch tễ và yếu tố nguy cơ nhiễm ấu trùng giun Toxocara sp ở một số điểm tại Bình Định và Gia Lai. Tạp chí Y học Thành phố Hồ Chí Minh. 2012;16(3):91–97.
5. Lê Đình Vĩnh Phúc, Nguyễn Bảo Toàn, Lê Hữu Lợi. Đặc điểm dịch tễ, lâm sàng, cận lâm sàng ở bệnh nhân nhiễm Toxocara sp tại Trung tâm Y khoa Medic Thành phố Hồ Chí Minh năm 2016. Tạp chí Y học Dự phòng. 2017;27(1):148–155.
6. Nguyễn Văn Chương, Huỳnh Hồng Quang, Bùi Văn Tuấn. Nghiên cứu một số đặc điểm lâm sàng, cận lâm sàng trên bệnh ấu trùng giun đũa chó ở người tại miền Trung – Tây Nguyên và hiệu lực điều trị bằng Albendazole. Tạp chí Phòng chống bệnh sốt rét và các bệnh ký sinh trùng. 2014;4:3–13.
7. Yoon S Y, Baek S, Park S Y, et al. Clinical course and treatment outcomes of toxocariasis-related eosinophilic disorder. Medicine. 2018; 97(37):e12361.
8. Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. Journal of helminthology. 2001;75(4):299-305.